USPTO serial 99347833
SABAI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 24, 2026
- Examiner
- CIANCI, RYAN MICHAEL
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SABAI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Chesterfield, MO, US
Chesterfield, MO, US
Chesterfield, MO, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew G. Minder
Matthew G. Minder Bryan Cave Leighton Paisner LLP211 North Broadway, Suite 3600St. Louis, MO 63102United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Providing independent review of clinical trials for business purposes; Providing institutional biosafety committee services, namely, providing independent review and oversight of scientific research and clinical trials for business purposes; Business administration of institutional biosafety committees; Professional staffing services and staff management of institutional review boards, institutional biosafety committees and conflicts of interest; Business administrative assistance, namely, business support services for the preparation and filing of institutional biosafety committee forms for use in the field of human subjects research; Business management and consultation in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval | ACTIVE | — |
| 042 | Providing medical and scientific research information in the field of clinical trials | ACTIVE | — |
| 045 | Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; Reviewing standards and practices to assure compliance with scientific research and clinical trial laws and regulations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sabai Group LLC
- Other trademarks owned by Sabai Group LLC
- Other trademarks owned by Sabai Group LLC
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named SABAI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 24, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 24, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 3, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 3, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 28, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 9, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 9, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 8, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 20, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 20, 2025 | NWAP | NEW APPLICATION ENTERED | — |